p55γ functional mimetic peptide N24 blocks vascular proliferative disorders

Area of Science:

• Cardiovascular Biology
• Molecular Medicine
• Cell Signaling

Background:

• Vascular smooth muscle cell (VSMC) proliferation and migration are key drivers of cardiovascular diseases.
• Despite drug development, cardiovascular diseases remain a leading cause of mortality.
• Novel therapeutic targets for controlling VSMC growth are urgently needed.

Purpose of the Study:

• To investigate the role of the p55γ subunit of phosphoinositide 3-kinase in VSMC regulation.
• To evaluate the therapeutic potential of a novel peptide, N24, derived from p55γ.
• To elucidate the molecular mechanisms underlying N24's effects on VSMC proliferation.

Main Methods:

• Adenovirus-mediated gene delivery and TAT-conjugated peptide administration in a rat carotid artery injury model.
• In vitro studies assessing VSMC proliferation and migration induced by growth factors.
• Analysis of cell cycle progression and molecular signaling pathways, including p53 and p21.

Main Results:

• N24 administration significantly reduced neointimal formation after balloon injury in rats.
• Overexpression of N24 suppressed serum- or PDGF-BB-induced VSMC proliferation and migration.
• N24 induced cell cycle arrest at the S phase by stabilizing p53 and upregulating p21, without causing cell death.

Conclusions:

• N24 acts as a functional mimetic of p55γ, inhibiting VSMC proliferation and migration.
• The N24 peptide targets the p53-p21 pathway to induce cell cycle arrest.
• N24 demonstrates significant therapeutic potential for treating proliferative cardiovascular diseases.